NMUR1

Chr 2

neuromedin U receptor 1

Also known as: (FM-3), FM-3, FM3, GPC-R, GPR66, NMU1R

This protein functions as a receptor for the neuromedin-U and neuromedin-S neuropeptides, mediating calcium and chloride signaling in neuronal membranes. Mutations in NMUR1 have been associated with neurodevelopmental disorders, though the gene shows low constraint to loss-of-function variants (pLI near 0, LOEUF 1.27), suggesting tolerance to such mutations. The inheritance pattern and specific clinical phenotypes require further characterization.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
9
Pubs (1 yr)
28
P/LP submissions
0%
P/LP missense
1.27
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryNMUR1
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
28 unique Pathogenic / Likely Pathogenic· 80 VUS of 128 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.27LOEUF
pLI 0.000
Z-score 0.93
OE 0.70 (0.411.27)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.23Z-score
OE missense 0.96 (0.871.06)
272 obs / 283.0 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.70 (0.411.27)
00.351.4
Missense OE0.96 (0.871.06)
00.61.4
Synonymous OE1.07
01.21.6
LoF obs/exp: 8 / 11.4Missense obs/exp: 272 / 283.0Syn Z: -0.61
DN
0.77top 25%
GOF
0.82top 10%
LOF
0.2582th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

128 submitted variants in ClinVar

Classification Summary

Pathogenic27
Likely Pathogenic1
VUS80
Likely Benign11
Benign4
27
Pathogenic
1
Likely Pathogenic
80
VUS
11
Likely Benign
4
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
27
0
27
Likely Pathogenic
0
0
1
0
1
VUS
0
78
2
0
80
Likely Benign
0
7
1
3
11
Benign
0
1
0
3
4
Total086316123

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

NMUR1 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Full-Text Mentions
NLP-detected gene mentions in article bodies · via PubTator3
PubTator3
Top 5 full-text resultsSearch PubTator3 ↗